Crossmark

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020

Crossref DOI link: https://doi.org/10.1016/j.bjid.2023.102759

Published Print: 2023-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wise, Mark G. http://orcid.org/0000-0001-7356-1851
Karlowsky, James A.

Lemos-Luengas, Elkin V.

Valdez, Rafael R.

Sahm, Daniel F.
Funding

Funding for this research was provided by:

Pfizer
License Information

Text and Data Mining valid from 2023-05-01

Text and Data Mining valid from 2023-05-01

Version of Record valid from 2023-03-15
More Information

This article is maintained by: Elsevier

Article Title: Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2023.102759

Content Type: article

Copyright: © 2023 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below